Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Schizophrenia

Free Subscription Articles published in Can J Psychiatry Retrieve available abstracts of 28 articles: HTML format

Single Articles

March 2026
1. WHITE N, Potvin S, Do A, Stip E, et al
   Cognitive Complaints in Schizophrenia: A Meta-Analysis of Studies Using the Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS): Les plaintes cognitives dans la schizophrenie : Une meta-analyse des etudes utilisant la Subjective Scale
   Can J Psychiatry. 2026 Mar 3:7067437261425086. doi: 10.1177/07067437261425086.
   PubMed     Abstract available
   
   
   
2. FRANKOW L, Bousman CA, Mathew N, Rafizadeh R, et al
   Clozapine Therapy With or Without Antipsychotic Augmentation: A Retrospective Evaluation of Prescribing Practices in a Canadian Provincial Residential Treatment Centre for Concurrent Disorders: Traitement par la clozapine avec ou sans intensification
   Can J Psychiatry. 2026;71:210-218.
   PubMed     Abstract available
   
   
   February 2026
3. BARKER LC, Zaheer J, Wong-Lee R, Kearney H, et al
   Building a Sexual and Reproductive Health Module for Implementation in Early Psychosis Programs: A Co-creation Process: Creation d'un module sur la sante sexuelle et reproductive a mettre en oeuvre dans les programmes d'intervention precoce en cas de
   Can J Psychiatry. 2026 Feb 18:7067437261420713. doi: 10.1177/07067437261420713.
   PubMed     Abstract available
   
   
   December 2025
4. MARTIN H, Valle R, Pawliuk N, Iyer SN, et al
   Family-Focused Recommendations in Canadian Guidelines for Early Intervention Services for Psychosis: A Systematic Review: Recommandations axees sur la famille dans les Lignes directrices canadiennes relatives aux services d'intervention precoce en cas
   Can J Psychiatry. 2025 Dec 10:7067437251393981. doi: 10.1177/07067437251393981.
   PubMed     Abstract available
   
   
   October 2025
5. SKIBA RM, Chinchani AM, Menon M, Lepage M, et al
   A multisite study of the overlap between symptoms and cognition in schizophrenia: Une etude multicentrique sur le chevauchement entre les symptomes et les troubles cognitifs chez les personnes atteintes de schizophrenie.
   Can J Psychiatry. 2025 Oct 22:7067437251387565. doi: 10.1177/07067437251387565.
   PubMed     Abstract available
   
   
   September 2025
6. LIU S, Tang S, Tan Y, Xiang B, et al
   Influence of Virtual Reality on Negative Symptoms and Quality of Life of Patients With Schizophrenia: A Meta-Analysis: Influence de la realite virtuelle sur les symptomes negatifs et la qualite de vie des patients atteints de schizophrenie : une meta-
   Can J Psychiatry. 2025 Sep 2:7067437251372186. doi: 10.1177/07067437251372186.
   PubMed     Abstract available
   
   
   July 2025
7. COPPOLA AM, McDonald J, Jimenez AM, Cao J, et al
   Non-Linear Relationships of Loneliness with Age in People Living with Schizophrenia and Non-Psychiatric Comparison Participants: Relations non lineaires entre la solitude et l'age chez les personnes atteintes de schizophrenie et les personnes n'ayant
   Can J Psychiatry. 2025 Jul 28:7067437251355636. doi: 10.1177/07067437251355636.
   PubMed     Abstract available
   
   
   
8. COLIJN MA
   Rare Genetic Variation and Psychosis: Treatment Considerations for Psychiatrists.
   Can J Psychiatry. 2025 Jul 21:7067437251339793. doi: 10.1177/07067437251339793.
   PubMed    
   
   
   
9. WIENER JC, Rodrigues R, Reid JNS, Archie S, et al
   Early Psychosis Symptoms Noted by Family Physicians in Electronic Medical Records During Help-Seeking Visits in Primary Care: Symptomes precoces de psychose releves par les medecins generalistes dans les dossiers medicaux electroniques lors de consult
   Can J Psychiatry. 2025 Jul 7:7067437251355637. doi: 10.1177/07067437251355637.
   PubMed     Abstract available
   
   
   May 2025
10. LEVIN Y, Mazza A, Hyland P, Karatzias T, et al
    Positive Symptoms of Psychosis and International Classification of Diseases 11th Revision (ICD-11) Complex Post-traumatic Stress Disorder: A Network Analysis in a Canadian Sample from Montreal: Symptomes positifs de psychose et trouble de stress post-
    Can J Psychiatry. 2025 May 15:7067437251337645. doi: 10.1177/07067437251337645.
    PubMed     Abstract available
    
    
    April 2025
11. ROTENBERG M, Graffi J, Anderson K, Kurdyak P, et al
    A Geospatial Analysis of Early Psychosis Intervention Programs in Toronto, Canada: Une analyse geospatiale des programmes d'intervention precoce en cas de psychose a Toronto, au Canada.
    Can J Psychiatry. 2025 Apr 29:7067437251337807. doi: 10.1177/07067437251337807.
    PubMed     Abstract available
    
    
    
12. LU Y, Hedemann TL, Hawke LD, Ampofo A, et al
    Adaptation of a Psychosocial Intervention for Canadian Youth at Clinical High Risk for Psychosis: Adaptation d'une intervention psychosociale pour les jeunes a haut risque clinique de psychose au Canada.
    Can J Psychiatry. 2025 Apr 13:7067437251328357. doi: 10.1177/07067437251328357.
    PubMed     Abstract available
    
    
    
13. METIVIER L, Trehout M, Leroux E, Rotharmel M, et al
    French Validation of the Brief Negative Symptom Scale (BNSS).
    Can J Psychiatry. 2025;70:312-319.
    PubMed     Abstract available
    
    
    March 2025
14. RAE J, Lavigne KM, Sauve G, Lepage M, et al
    Mapping Insight Dimensions and Symptom Dynamics in Schizophrenia: A Data-Driven Network Approach: Cartographie des dimensions d'insight et de la dynamique symptomatique dans la schizophrenie: une approche par reseau fondee sur les donnees.
    Can J Psychiatry. 2025 Mar 21:7067437251329074. doi: 10.1177/07067437251329074.
    PubMed     Abstract available
    
    
    
15. ZIPURSKY RB, Agid O, Kiang M, Remington G, et al
    Clinical Correlates of Antipsychotic Plasma Levels with Long-Acting Paliperidone: Correlats cliniques des concentrations plasmiques de paliperidone a liberation prolongee.
    Can J Psychiatry. 2025;70:209-216.
    PubMed     Abstract available
    
    
    December 2024
16. ZIPURSKY RB
    Rethinking Schizophrenia-A Manageable Chronic Condition.
    Can J Psychiatry. 2024 Dec 10:7067437241301572. doi: 10.1177/07067437241301572.
    PubMed    
    
    
    
17. VAN L, Heung T, Reyes NGD, Boot E, et al
    Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde reel de la schizophrenie chez des adultes atteints du syndrome de microdeletion 22q11.2.
    Can J Psychiatry. 2024 Dec 6:7067437241293983. doi: 10.1177/07067437241293983.
    PubMed     Abstract available
    
    
    
18. WEIDENAUER A, Garani R, Campos Oller P, Belen Blasco M, et al
    Impact of Stress on the Endocannabinoid System: A [(11)C]-CURB Positron Emission Tomography Study in Early Psychosis: Les effets du stress sur le systeme endocannabinoide : etude par tomographie par emission de positons avec l'indicateur radioactif [1
    Can J Psychiatry. 2024 Dec 4:7067437241300958. doi: 10.1177/07067437241300958.
    PubMed     Abstract available
    
    
    November 2024
19. DEVOE DJ, Liu L, Braun A, Cadenhead KS, et al
    Cognitive-Behavioural Social Skills Training: Mediation of Treatment Outcomes in a Randomized Controlled Trial for Youth at Risk of Psychosis: L'entrainement aux competences sociales cognitivo-comportementales : variables mediatrices des resultats the
    Can J Psychiatry. 2024 Nov 11:7067437241295636. doi: 10.1177/07067437241295636.
    PubMed     Abstract available
    
    
    
20. KASTER TS, Babujee A, Sharpe I, Rhee TG, et al
    Clinical Characteristics of Inpatients with Schizophrenia Spectrum Disorder Treated with Electroconvulsive Therapy: A Population-Level Cross-Sectional Study: Titre: Caracteristiques cliniques des patients hospitalises presentant un trouble du spectre
    Can J Psychiatry. 2024 Nov 11:7067437241290181. doi: 10.1177/07067437241290181.
    PubMed     Abstract available
    
    
    
21. FAN L, Zhang Z, Ma X, Liang L, et al
    Brain Age Gap as a Predictor of Early Treatment Response and Functional Outcomes in First-Episode Schizophrenia: A Longitudinal Study: L'ecart d'age cerebral comme predicteur de la reponse en debut de traitement et des resultats fonctionnels dans un p
    Can J Psychiatry. 2024 Nov 10:7067437241293981. doi: 10.1177/07067437241293981.
    PubMed     Abstract available
    
    
    
22. ALARABI M, Burton L, Powell V, Isinger T, et al
    Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensee et neurocognition dans la schizophrenie refractaire.
    Can J Psychiatry. 2024 Nov 4:7067437241293985. doi: 10.1177/07067437241293985.
    PubMed     Abstract available
    
    
    
23. BARBER S, Mulushoa A, Hanlon C, Malla A, et al
    Psychosis and Gender: A Focus on Women in the Global South.
    Can J Psychiatry. 2024 Nov 3:7067437241295301. doi: 10.1177/07067437241295301.
    PubMed    
    
    
    October 2024
24. KORANN V, Panganiban KJ, Stogios N, Remington G, et al
    The Dysregulation of the Glymphatic System in Patients with Psychosis Spectrum Disorders Minimally Exposed to Antipsychotics: La deregulation du systeme glymphatique en presence de troubles psychotiques chez des patients peu exposes a des antipsychoti
    Can J Psychiatry. 2024 Oct 21:7067437241290193. doi: 10.1177/07067437241290193.
    PubMed     Abstract available
    
    
    July 2024
25. LEPAGE M, Guimond S, Raedler T, McNeely HE, et al
    Strategies for Achieving Better Cognitive Health in Individuals with Schizophrenia Spectrum: A Focus on the Canadian Landscape: Strategies pour atteindre une meilleure sante cognitive chez les personnes souffrant du spectre de la schizophrenie : un re
    Can J Psychiatry. 2024 Jul 25:7067437241261928. doi: 10.1177/07067437241261928.
    PubMed     Abstract available
    
    
    April 2024
26. CORONADO-MONTOYA S, Abdel-Baki A, Crockford D, Cote J, et al
    Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Preferences des jeunes adultes souffrant de psychose pour les interventions de reduction des mefaits axees sur le cannabis : une etu
    Can J Psychiatry. 2024 Apr 4:7067437241242395. doi: 10.1177/07067437241242395.
    PubMed     Abstract available
    
    
    February 2024
27. L'HEUREUX S, Huot-Lavoie M, Bergeron A, Bergeron C, et al
    Effect of Cannabis Legalization in Canada on the Incidence of Psychosis Consultations in Quebec City's Psychiatric Emergency Services.
    Can J Psychiatry. 2024 Feb 21:7067437241232901. doi: 10.1177/07067437241232901.
    PubMed    
    
    
    September 2023
28. CHEN S, Lee A, Wang W
    A Meta-Research of Randomized Controlled Trials in the Field of Mental Health: Comparing Pharmacological to Non-Pharmacological Interventions from 1955 to 2020.
    Can J Psychiatry. 2023;68:639-648.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum